Proto Labs (NYSE:PRLB) Upgraded to “Buy” by Zacks Investment Research

Proto Labs (NYSE:PRLB) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday, January 13th. The brokerage presently has a $120.00 price objective on the industrial products company’s stock. Zacks Investment Research‘s target price would suggest a potential upside of 10.14% from the stock’s current price.

According to Zacks, “Proto Labs, Inc. is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. It produces CNC machined and injection molded plastic parts. Proto Labs targets their services to product developers who use three-dimensional computer-aided design to develop products across a diverse range of end-markets. The Company has locations in the United States, the United Kingdom, Germany, Japan, Italy, France, and Spain. Proto Labs, Inc. is headquartered in Maple Plain, Minnesota. “

Other equities analysts also recently issued reports about the company. Piper Jaffray Companies restated a “hold” rating and issued a $84.00 price objective on shares of Proto Labs in a research report on Thursday, December 14th. Craig Hallum set a $92.00 target price on Proto Labs and gave the stock a “hold” rating in a research report on Monday, November 27th. Finally, BidaskClub downgraded Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 6th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $86.50.

Shares of Proto Labs (PRLB) traded down $1.60 during trading on Friday, hitting $108.95. The stock had a trading volume of 169,598 shares, compared to its average volume of 118,607. Proto Labs has a fifty-two week low of $48.00 and a fifty-two week high of $113.05. The stock has a market capitalization of $2,903.08, a P/E ratio of 62.26, a price-to-earnings-growth ratio of 2.37 and a beta of 1.08.

In related news, Director Rainer Gawlick sold 500 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the transaction, the director now owns 10,925 shares of the company’s stock, valued at $1,122,543.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Robert Bodor sold 4,000 shares of the stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $94.79, for a total value of $379,160.00. Following the completion of the transaction, the vice president now directly owns 20,578 shares in the company, valued at approximately $1,950,588.62. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 19,556 shares of company stock worth $1,814,101. Insiders own 7.78% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Proto Labs by 52.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,375 shares of the industrial products company’s stock valued at $142,000 after purchasing an additional 471 shares during the last quarter. Victory Capital Management Inc. raised its stake in Proto Labs by 17.7% in the 2nd quarter. Victory Capital Management Inc. now owns 2,323 shares of the industrial products company’s stock worth $156,000 after acquiring an additional 349 shares during the last quarter. Hengehold Capital Management LLC purchased a new position in Proto Labs in the 4th quarter worth $254,000. Cubist Systematic Strategies LLC purchased a new position in Proto Labs in the 3rd quarter worth $238,000. Finally, Hanseatic Management Services Inc. acquired a new stake in Proto Labs during the 3rd quarter worth about $243,000.

COPYRIGHT VIOLATION NOTICE: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/04/proto-labs-prlb-raised-to-buy-at-zacks-investment-research.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply